BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18483244)

  • 1. Myc-mediated transcriptional repression by recruitment of histone deacetylase.
    Kurland JF; Tansey WP
    Cancer Res; 2008 May; 68(10):3624-9. PubMed ID: 18483244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism.
    Barsyte-Lovejoy D; Mao DY; Penn LZ
    Oncogene; 2004 Apr; 23(19):3481-6. PubMed ID: 15021909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo GSH depletion induces c-myc expression by modulation of chromatin protein complexes.
    Torres L; Sandoval J; Penella E; Zaragozá R; García C; Rodríguez JL; Viña JR; García-Trevijano ER
    Free Radic Biol Med; 2009 Jun; 46(11):1534-42. PubMed ID: 19289167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms.
    Sun H; Taneja R
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4058-63. PubMed ID: 10737769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
    Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
    Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
    Ho JS; Ma W; Mao DY; Benchimol S
    Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
    Popov N; Wahlström T; Hurlin PJ; Henriksson M
    Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1.
    Huang W; Tan D; Wang X; Han S; Tan J; Zhao Y; Lu J; Huang B
    Biochem Biophys Res Commun; 2006 Jan; 339(1):165-71. PubMed ID: 16298343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
    Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.
    Villa R; Morey L; Raker VA; Buschbeck M; Gutierrez A; De Santis F; Corsaro M; Varas F; Bossi D; Minucci S; Pelicci PG; Di Croce L
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1400-5. PubMed ID: 16432238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
    Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
    Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc-regulated microRNAs modulate E2F1 expression.
    O'Donnell KA; Wentzel EA; Zeller KI; Dang CV; Mendell JT
    Nature; 2005 Jun; 435(7043):839-43. PubMed ID: 15944709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer.
    Camarero N; Mascaró C; Mayordomo C; Vilardell F; Haro D; Marrero PF
    Mol Cancer Res; 2006 Sep; 4(9):645-53. PubMed ID: 16940161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a novel histone deacetylase 1/c-Myc/Mnt/Max complex formation is implicated in parity-induced refractoriness to mammary carcinogenesis.
    Matsuoka Y; Fukamachi K; Uehara N; Tsuda H; Tsubura A
    Cancer Sci; 2008 Feb; 99(2):309-15. PubMed ID: 18271930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism of COOH-terminal binding protein-mediated repression.
    Meloni AR; Lai CH; Yao TP; Nevins JR
    Mol Cancer Res; 2005 Oct; 3(10):575-83. PubMed ID: 16254191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
    Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
    Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the N-terminal domain of the Myc oncoprotein.
    Oster SK; Mao DY; Kennedy J; Penn LZ
    Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
    Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
    Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.
    Marshall GM; Gherardi S; Xu N; Neiron Z; Trahair T; Scarlett CJ; Chang DK; Liu PY; Jankowski K; Iraci N; Haber M; Norris MD; Keating J; Sekyere E; Jonquieres G; Stossi F; Katzenellenbogen BS; Biankin AV; Perini G; Liu T
    Oncogene; 2010 Nov; 29(44):5957-68. PubMed ID: 20697349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.